stars 1 stars 2 stars 3

Azyro develops bioelectronic medical devices for wound care and infection control. Chronic wounds are hard to treat. Antibiotics struggle against resistant bacteria. Dressings work on the surface. Too many patients face long recoveries, and some face amputation. Our answer is magnetic fields. It's non-invasive and non-contact, so it never touches the wound. It is designed to reach deeper tissue layers where conventional treatments fall short. The technology aims to: – Accelerate wound healing – Reduce microbial burden – Relieve pain – Help prevent amputations Faster recovery also means lower costs for healthcare systems. The system is modular and scalable, built for both hospital and home care. It's safe and simple to use. It fits into existing treatment pathways and IT environments without disrupting established workflows. Our pre-clinical results have been very promising. Azyro is the 2026 winner of the Luxembourg Healthtech Adoption Award, with the support of the Ministry of the Economy. Based in Luxembourg. Building better outcomes for patients with chronic wounds.

Employees 8 (5 on RocketReach)
Founded 2021
Industry Medical Devices

Azyro SA Questions

Jerry Wagner is the Marketing Communications Director of Azyro SA.

5 people are employed at Azyro SA.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users